Developing ‘Omomyc’ as a new cancer drug
- Researcher: Dr Laura Soucek
- Institution: Fundacio Institut d'Investigacio Oncologica Vall Hebron (VHIO)
- Award Amount: £170,357 for 3 years from June 2013
- Cancer Type: Lung Cancer
Dr Soucek is working on one way to tackle this problem, by blocking a protein called myc. Myc is common to many cancers and is a component of so many cell growth pathways. Dr Soucek’s group have developed a myc-blocking protein fragment called omomyc that has been shown in animal models to be very effective at stopping cancer growth. But the problem that prevents it from being used in humans is that omomyc is not able to get into cancer cells easily, a crucial property that any cancer drug must have.
This Worldwide Cancer Research project looks specifically at how omomyc might be chemically modified so that it can move easily into cancer cells by itself. Modified omomyc protein fragments will then be tested to see if they can eliminate lung cancer in a mouse model. This project represents a crucial step in the drug development process that will, if successful, turn omomyc from scientific tool to potential new cancer drug, and open up the prospect of future clinical trials.
Showing: All projects
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.
Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....Read more